Buscar
Mostrando ítems 81-90 de 776
Effects of metformin on the glycemic control, lipid profile, and arterial blood pressure of type 2 diabetic patients with metabolic syndrome already on insulin
(Associação Brasileira de Divulgação Científica, 2006-04-01)
Fifty-seven type 2 diabetic patients with metabolic syndrome and on insulin were assessed by a paired analysis before and 6 months after addition of metformin as combination therapy to evaluate the impact of the association ...
Are the beneficial cardiovascular effects of simvastatin and metformin also associated with a hormone-dependent mechanism improving insulin sensitivity?
(Associação Brasileira de Divulgação Científica, 2007-02-01)
In addition to lipid-lowering and cardiovascular protective actions, statins may have beneficial effects on insulin sensitivity. The objective of the present study was to evaluate the effect of simvastatin therapy on insulin ...
Metformin versus lifestyle changes in treating women with polycystic ovary syndrome
(INFORMA HEALTHCARENEW YORK, 2012)
Objective: To compare the efficacy of metformin with that of lifestyle changes in patients with polycystic ovary syndrome (PCOS). Design: Prospective, randomized clinical trial of 40 women with PCOS to analyze the effects ...
Obesity: effects of physical exercise and metformin on metabolic aspects of monosodium glutamate treated rats
(Editrice Kurtis S R L, 2013)
Metabolic effect of metformin in obese adolescents at risk of diabetes mellitus type 2 Efecto metabólico de la metformina en adolescentes obesas con riesgo de diabetes mellitus tipo 2
(2012)
In adults, metformin promotes weight loss and prevents the development of type 2 diabetes mellitus (DM2). However, these effects have not been demonstrated in adolescents at risk for DM2. Objective: To analyze the ...
Metformin as an add-on to insulin improves periodontal response during orthodontic tooth movement in type 1 diabetic rats
(2019-08-01)
BACKGROUND: Type 1 diabetes (T1D) is associated with delayed tissue healing and bone loss. Periodontal tissues during tooth movement (OTM) in T1D and under diabetic treatment are poorly understood. We aimed to study the ...
Metformin inhibits platelet-mediated ovarian cancer cell progression
(2016)
Introduction: Increased platelets count (thrombocytosis) is associated with poor patient
prognosis an in vitro Investigation has shown that platelets induce cancer cell survival and
dissemination. The anti-diabetic drug ...
Metformin inhibit the effect of platelets on promotion of ovarian cancer cells
(2015)
Introduction: An increase in circulating platelets, or thrombocytosis, is recognized as an independent risk factor of bad prognosis and metastasis in patients with ovarian cancer. The antidiabetic drug Metformin has been ...
Metformin reduces platelet-increased angiogenesis
(2015)
Introduction: Increased platelet number (Thrombocytosis) in cancer is correlated with poor prognostic. Platelets are known to increase angiogenesis, a process essential to cancer propagation. The anti-diabetic drug, ...